BICO Group logo

BICO Group

Stock
Stock
ISIN: SE0013647385
Ticker: BICO
SE0013647385
BICO

Price

Price

CHART BY

Frequently asked questions

What is BICO Group's market capitalization?

The market capitalization of BICO Group is $206.82M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for BICO Group?

BICO Group's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.603. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for BICO Group's stock?

Currently, 3 analysts cover BICO Group's stock, with a consensus target price of $9.061. Analyst ratings provide insights into the stock's expected performance.

What is BICO Group's revenue over the trailing twelve months?

Over the trailing twelve months, BICO Group reported a revenue of $197.21M.

What is the EBITDA for BICO Group?

BICO Group's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $9.02M. EBITDA measures the company's overall financial performance.

What is the free cash flow of BICO Group?

BICO Group has a free cash flow of $8.51M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the free float of BICO Group's shares?

The free float of BICO Group is 43.16M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$206.82M
EPS (TTM) 
-$1.603
Free Float 
43.16M
Revenue (TTM) 
$197.21M
EBITDA (TTM) 
$9.02M
Free Cashflow (TTM) 
$8.51M

Pricing

1D span
$2.855$2.99
52W span
$2.666$6.264

Analyst Ratings

The price target is $9.061 and the stock is covered by 3 analysts.

Buy

3

Hold

0

Sell

0

Information

BICO Group AB engages in the provision of technologies, products, and services to create, understand, and master biology. It operates through the following segments: Bioprinting, Biosciences, Bioautomation, and Group. The Bioprinting segment includes 3D bioprinters and bioinks with a wide range of technologies for different demanding applications, resolutions, and volume and speed requirements, as well as services focused on accelerating drug discovery and development with advanced tissue imaging and cell culture services. The Biosciences segment focuses on supplying advanced lab instrumentation and smart workflow connectivity software to analyze data from applications in cell culture, cell imaging, cell sorting, and sample preparation for different analytics such as genomics. The Bioautomation segment offers scientific instruments and solutions for scalable manufacturing of diagnostics, as well as consumables to enable single-cell and other workflows. The Group segment is involved in the group’s administration and shareholder costs. The company was founded by Erik Paul Gatenholm and Hector Daniel Martinez Avila in March 2015 and is headquartered in Gothenburg, Sweden.

Industries
Biotechnology
Sector
Health Care

Identifier

ISIN
SE0013647385
Primary Ticker
BICO

Knockouts

Join the conversation